Correlation Between BioCryst Pharmaceuticals and TG Therapeutics
Can any of the company-specific risk be diversified away by investing in both BioCryst Pharmaceuticals and TG Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioCryst Pharmaceuticals and TG Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioCryst Pharmaceuticals and TG Therapeutics, you can compare the effects of market volatilities on BioCryst Pharmaceuticals and TG Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioCryst Pharmaceuticals with a short position of TG Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioCryst Pharmaceuticals and TG Therapeutics.
Diversification Opportunities for BioCryst Pharmaceuticals and TG Therapeutics
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between BioCryst and TGTX is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding BioCryst Pharmaceuticals and TG Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TG Therapeutics and BioCryst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioCryst Pharmaceuticals are associated (or correlated) with TG Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TG Therapeutics has no effect on the direction of BioCryst Pharmaceuticals i.e., BioCryst Pharmaceuticals and TG Therapeutics go up and down completely randomly.
Pair Corralation between BioCryst Pharmaceuticals and TG Therapeutics
Given the investment horizon of 90 days BioCryst Pharmaceuticals is expected to generate 4.06 times less return on investment than TG Therapeutics. But when comparing it to its historical volatility, BioCryst Pharmaceuticals is 1.28 times less risky than TG Therapeutics. It trades about 0.05 of its potential returns per unit of risk. TG Therapeutics is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest 1,630 in TG Therapeutics on August 29, 2024 and sell it today you would earn a total of 1,870 from holding TG Therapeutics or generate 114.72% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
BioCryst Pharmaceuticals vs. TG Therapeutics
Performance |
Timeline |
BioCryst Pharmaceuticals |
TG Therapeutics |
BioCryst Pharmaceuticals and TG Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BioCryst Pharmaceuticals and TG Therapeutics
The main advantage of trading using opposite BioCryst Pharmaceuticals and TG Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioCryst Pharmaceuticals position performs unexpectedly, TG Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TG Therapeutics will offset losses from the drop in TG Therapeutics' long position.BioCryst Pharmaceuticals vs. TG Therapeutics | BioCryst Pharmaceuticals vs. Axsome Therapeutics | BioCryst Pharmaceuticals vs. Seres Therapeutics | BioCryst Pharmaceuticals vs. Madrigal Pharmaceuticals |
TG Therapeutics vs. Madrigal Pharmaceuticals | TG Therapeutics vs. Terns Pharmaceuticals | TG Therapeutics vs. Hepion Pharmaceuticals | TG Therapeutics vs. Exelixis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |